{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:44:21Z","timestamp":1793324661833,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Mutations in the\n                      <jats:italic toggle=\"yes\">KCNJ5<\/jats:italic>\n                      (potassium inwardly rectifying channel subfamily J member 5) gene, encoding an inwardly rectifying potassium channel, can drive aldosterone overproduction in a subset of aldosterone-producing adenomas and in familial hyperaldosteronism type III. Our objective was to identify small molecule compounds that specifically antagonize mutant KCNJ5 channels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Virtual screening of over 6 million small molecules identified compounds that putatively bind to KCNJ5 channels. The effect of 108 of these candidates was evaluated in vitro in human adrenocortical cells (HAC15) with inducible expression of wild-type or mutated forms of\n                      <jats:italic toggle=\"yes\">KCNJ5<\/jats:italic>\n                      . Assessment encompassed cell viability, flow cytometry, gene expression, and adrenal steroid quantification via liquid chromatography\u2013tandem mass spectrometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Compounds antagonizing mutated KCNJ5 function were identified by evaluating their ability to rescue adrenal cell death induced by overexpression of mutant\n                      <jats:italic toggle=\"yes\">KCNJ5<\/jats:italic>\n                      . A spiroquinoline compound, referred to as compound 81 (C81), effectively rescued cell death induced by KCNJ5 L168R in both monolayer and spheroid HAC15 cell cultures. C81 treatment caused a 69% to 85% reduction in\n                      <jats:italic toggle=\"yes\">CYP11B2<\/jats:italic>\n                      (aldosterone synthase) mRNA levels induced by\n                      <jats:italic toggle=\"yes\">KCNJ5<\/jats:italic>\n                      L168R, G151R, or T158A expression, compared with untreated cells. C81 also reduced aldosterone secretion by 65% in cells expressing KCNJ5 L168R and decreased 18-oxocortisol and 18-hydroxycortisol production by 78% and 90%, respectively. However, C81 had no significant effect on steroid secretion in cells overexpressing wild-type KCNJ5.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      C81 shows potential as a small molecule antagonist to specifically target pathological aldosterone secretion in familial hyperaldosteronism type III or\n                      <jats:italic toggle=\"yes\">KCNJ5<\/jats:italic>\n                      -mutated aldosterone-producing adenomas. These findings suggest new avenues for genotype-based primary aldosteronism diagnostics and targeted treatments, contributing to personalized patient care.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/hypertensionaha.125.25360","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:00:42Z","timestamp":1763632842000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Aldosteronism: Small Molecule Antagonists of Mutant KCNJ5 Potassium Channels"],"prefix":"10.1161","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9051-1424","authenticated-orcid":true,"given":"Sanas","family":"Mir-Bashiri","sequence":"first","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tetti","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."},{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Italy (M.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Fr\u00f6bel","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine (D.F., M.P., N.B.), University Hospital and Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-9055","authenticated-orcid":true,"given":"Yuhong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."},{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, China (Y.Y.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Reiss","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6174-8820","authenticated-orcid":true,"given":"Jonas","family":"Bibus","sequence":"additional","affiliation":[{"name":"Dr. von Hauner Children\u2019s Hospital, LMU Klinikum (J.B.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2472-675X","authenticated-orcid":true,"given":"Mirko","family":"Peitzsch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine (D.F., M.P., N.B.), University Hospital and Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-9903","authenticated-orcid":true,"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III (G.E.), University Hospital and Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-333X","authenticated-orcid":true,"given":"Nicole","family":"Bechmann","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine (D.F., M.P., N.B.), University Hospital and Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":true,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-6444","authenticated-orcid":true,"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital (S.M.-B., M.T., Y.P., Y.Y., D.R., M.R., T.A.W.), Ludwig Maximilians University Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000230444.01215.6a"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2805"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30367-4"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21474"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2015"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00753-6"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae041"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041926"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.186478"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1944"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.10.002"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0594"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.34"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1733"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00253-4"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2803"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2022.2061416"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-11-4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91733"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10226"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011825.pub2"},{"key":"e_1_3_3_28_2","first-page":"251","article-title":"Physiochemical factors influencing the stability of solubilized liver nuclear receptor-3,5,3\u2019-triiodothyronine complex in vitro.","volume":"21","author":"Brtko J","year":"1987","unstructured":"Brtko J, Knopp J, DeGroot LJ. Physiochemical factors influencing the stability of solubilized liver nuclear receptor-3,5,3\u2019-triiodothyronine complex in vitro. Endocrinol Exp. 1987;21:251\u2013256.","journal-title":"Endocrinol Exp"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2018.1436961"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04636"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13476"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21707"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.10.006"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2025.106736"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121407109"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050594"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2004.12.019"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06186"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16209"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13866"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c130037"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.86.342"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.125.25360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:00:58Z","timestamp":1777572058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.125.25360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.125.25360"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.125.25360","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-05-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}